In April 2014 there were 315 open clinical trials under way to understand and treat Alzheimer’s disease. 42 of these studies were open, human phase three trials, the last step before United States Food and Drug Administration (FDA) approval and marketing. In the decade 2002–2012, 244 compounds were assessed in…